连续葡萄糖监测装置市场份额，规模，趋势，行业分析报告的组件类型（变送器和接收器，传感器，胰岛素泵）;通过最终用途（医院，HomeCare诊断）;按地区（北美，欧洲，亚太地区，中东和非洲，拉丁美洲）;分部预测，2020 - 2026年

报告摘要

全球连续葡萄糖监测设备的市场规模在2019年的3,512.8亿美元上价值，预计预测期内的CAGR成长为15.8％。新产品开发和产品进入产品的先进功能极大地利用了过去的市场需求。每当血糖水平偏离规定的水平时的报警声，功能要添加额外的详细信息，如膳食时间，药物，身体活动等，能够连接到计算机产生葡萄糖趋势，直接设置糖尿病计划的能力，导致了糖尿病计划广泛采用产品。

连续葡萄糖监测（CGM）用于自动跟踪血液中的葡萄糖水平，通常称为血糖，绕时钟。该装置有助于实时更新血糖水平。它还有助于跟踪血糖水平并建立趋势代替各种因素，例如饮食计划，运动，禁食，时间等。

CGM products have inherent advantages over standard blood glucose meters. These advantages include better management and tracking of blood glucose levels due to continuous operation, elimination of the need to use finger sticks on a large scale, efficiently manage blood glucose emergencies, among others. All these advantages have resulted in wide adoption of CGM by patients having treatment of intensive insulin therapy, and or suffering from hypoglycemia unawareness or are suffering from high/low blood sugar levels among others. The rising number of these cases across the globe is expected to benefit the industry growth over the forecast period.

了解有关此报告的更多信息：请求样本Pages

旨在促进促进CGM的有利监管举措，预计将大幅促进产业增长。例如，在美国，CLIA的批准（临床实验室改善修正案）预计将在未来六年内使CGM需求受益。这些是批准用于非传统设置中的医疗保健提供者，包括急诊室，医师办公室，药房诊所，卫生乐动娱乐官网部诊所等的医疗保健提供者。

The growing instances of diabetes is expected to drive the Continuous Glucose Monitoring industry over the forecast period. Diabetes is considered as one of the most life-threatening disease and is the leading cause of death in various parts of the world. Diabetes has become one of the most dominant cause of mortality. Moreover, the prevalence of diabetes across the globe is also on a constant rise, thus proving as a driver for CGM sales. The below table highlights the prevalence of diabetes:

连续葡萄糖监测系统市场报告范围

The market is primarily segmented on the basis of Component Type, By End-Use, and by Geographic region.

按组件类型	通过最终使用	按地区
发射器和接收器 Sensors 胰岛素泵	医院 家庭护理诊断接头nostics Others	North America (U.S., Canada, Mexico) 欧洲（德国，西班牙，英国，意大利，法国，荷兰，比利时，俄罗斯） Asia Pacific (Japan, China, India, South Korea, Singapore, Malaysia, Indonesia, Thailand, Philippines) 拉丁美洲（巴西，墨西哥，阿根廷） MEA (Saudi Arabia, South Africa, UAE)

了解有关此报告的更多信息：请求样本Pages

Component Type Outlook

In 2019, sensors emerged as the Continuous Glucose Monitoring System Market segment having the largest growth. The transmitter is a small portable piece which can be fitted on the sensor. This device is capable of sending glucose data wirelessly from the attached sensor to the monitor. This can be also be sent to insulin pump if the sensor has been integrated to the pump.

It is equivalent to a small cell phone which can be carried in the pocket. This receiver needs to be carried by the user as this device has a display on it which gives the user the information sent by the transmitter. The receiver is capable of displaying the glucose level and also the trend of the glucose. The device is also capable of displaying the extreme highs and lows and alerts to the user. Many of the devices are also capable of sending information to the insulin pump which then pumps insulin to the user’s body.

Most of the sensors are applied to the abdomen while few are also approved to be used on the alternate body parts and generate reading pertaining to the glucose. This data is then sent to the receiver which displays the reading. The product has an adhesive which to hold the product in place.

在需要任何更换之前，传感器能够持续近一周。越来越多的可穿戴装置和可穿戴传感器的使用情况将推动不久的将来的产品需求。传感器使用常规测试条使用的类似酶，并检测用户体内的血糖水平。一周后，这需要更换。提高产品的进步将推动传感器市场。

最终使用前景

由于2019年最大的连续葡萄糖监测设备市场部门出现了HomeCare诊断，并且该部门也将在预测期结束之前继续其优势。增殖的访问次数或与糖尿病有关的频率将是增加医院CGM器件采用的关键原因。最近由于新的电晕病毒爆发FDA已批准了CGM设备在医院的使用情况。使用将进一步降低与其他人不必要的接触。2020年4月，Abbott宣布其计划由于Covid-19爆发而捐赠给医院的25,000名CGM传感器。

Home healthcare diagnostics segment is expected to witness growth owing to its cost effectiveness and comfort level it provides to the patients. CGMs also empowers the clinicians to address healthcare challenges and take decisions instantly. As the emphasis of healthcare is shifting towards early detection and prevention of diseases, the homecare diagnostics market is expected to witness lucrative growth during the forecast period.

区域前景

North America has high prevalence of diabetes which is a key factor boosting the overall demand of CGM devices. According to the research conducted by the U.S. federal government, 10% of the total deaths in the U.S. were due to the diabetes. This accounted for the third major cause for the deaths after heart and cancer diseases. The U.S. and Canada are among the countries with highest medical spending. High medical spending is the key factor for the strong market growth in the region. Further, the presence of the major companies in the region manufacturing these kits and their marketing efforts is making the adaption easy, thereby boosting sales. All these factors ensure strong Continuous Glucose Monitoring demand in the region.

欧洲包括超过5000万人左右ple suffering from diabetes. Germany, UK, France and other EU countries with large healthcare spending budget are the major markets for the CGM products. In addition, proliferating cutting edge technology in the region focusing on the individual health systems particularly diabetes is another major factor fueling the product growth. Growing number of people adopting the wearable devices will drive the product growth in Europe.

Competitive Landscape

Continuous Glucose Monitoring Companies are investing continuously in R&D activities in order to make CGMs more efficient and easier to use. Also, efforts are being made to make the devices more accurate. As of now, there exists a trust deficit pertaining to usage of only CGM results as the basis of treatment decisions, and there is a trend to conduct fingerstick glucose tests to double check the results. In addition, high costs involved pertaining to CGM usage is also a major impediment of the market. However, continuous development of product has bypassed these restraints to an extent.

Continuous Glucose Monitoring Companies such as Senseonics Holdings, Inc., Insulet Corporation, Bayer AG, Ypsomed Holding AG, LifeScan, Novo Nordisk, Medtronic PLC, Dexcom Inc., Abbott Diagnostics Inc., and Roche Diagnostics are some of the key players operating in the Continuous Glucose Monitoring Device Market.